HIV topical microbicides: the current development strategy is fully justified.
Stone
Alan B
AB
D000282:Administration, Intravaginal; D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000600:supply & distribution / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005544:Forecasting; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D018579:Patient Selection; D012107:Research Design; D012109:Research Support as Topic / Q000458:organization & administration; D012449:Safety; D014622:Vaginal Creams, Foams, and Jellies; D016387:Women's Health
D019380:Anti-HIV Agents; D000891:Anti-Infective Agents, Local; D014622:Vaginal Creams, Foams, and Jellies